Rheumnow Podcast
Believing is Doing (1.21.2022)

Believing is Doing (1.21.2022)

January 21, 2022

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. These reports are about better outcomes in Lupus; Less Gout flares with T2T and the power of belief.

The Overpricing of Drugs (1.14.2022)

The Overpricing of Drugs (1.14.2022)

January 14, 2022

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
RheumNow.Live is March 19, 20th in Dallas, TX

Comorbidities in axSpA- A Focus on Cardiovascular Features Sponsored by Novartis Medical Affairs

Comorbidities in axSpA- A Focus on Cardiovascular Features Sponsored by Novartis Medical Affairs

January 10, 2022

Patients with axial spondyloarthritis (axSpA) commonly experience cardiovascular (CV) comorbidities. There is a need to holistically assess a patient, including considerations for managing disease activity and understanding the safety profile of available therapies as it relates to comorbidities. Join Marina Magrey, MD as she provides insight on this topic for holistic patient-centered care. 

Please provide feedback on the session using this link https://bit.ly/3j4pA6u

2021 Rheumatology Year in Review  (1.7.2022)

2021 Rheumatology Year in Review (1.7.2022)

January 7, 2022

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.

Best of 2021 -Jack of All Subspecialties (12.31.2021)

Best of 2021 -Jack of All Subspecialties (12.31.2021)

December 31, 2021

New to RheumNow? 
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. 

In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com

A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections during fetal life or childhood did not increase risk of JIA. #RheumNow https://t.co/Md0zBm5Txl

Alendronate may protect against type 2 Diabetes. Data from National Danish Patient Registry, presented at the EASD meeting compared 160k T2DM & 500k controls, T2DM following alendronate adjusted OR=0.64; 0.62-0.66; ⋗8yrs OR=0.47 https://t.co/RYEZodUZtv

Analysis of 508 #RA pts (over 10 yrs) in the BeST study shows joint swelling at baseline resulted in half w/ re-swelling later and significantly increased risk of same joint swelling during follow-up (OR 2.37, 95% CI 2.30 to 2.43, p⋖0.001) https://t.co/a7zH4YRAkq

Finnish Pop study 939 #RA pts shows highest healthcare costs linked to high Dz activity & comorbidity. Clusters: C1) young w/ low costs & activity, C2) chronic pain, disability, fatigue, C3) high cost/dz activity, less pain, C4)comorbidities w/ $$$  https://t.co/Azc35zyA9J

A longitudinal study from Iceland shows an increasing number of native joint infections (NJI), with iatrogenic, postarthroscopic infections being of particular concern. Read more… https://t.co/j3gzZ9g0QV

Case controlled study suggests that intraarticular steroid injections is associated with increased (HR 8.56; 3.29-22.3) risk of rapidly destructive hip disease (RDHD); at a rate of 5.4% (5.1 mos post injx) w/ JSN, osteolysis, fem head collapse https://t.co/grX5bO4495

Biosimilar update: 31 FDA approved biosimilars, but only 60% made it to market. 2015 to 2019, drug spending grew 6.1%, biologic spending grew 14.6%; biologics are 43% of US drug spending. Most biosimilars at ~30% discount.  https://t.co/4paYH8yVLQ

Study Finds U.S. Generic and Biosimilar Savings Totaled a Record $338 Billion in 2020  https://t.co/hPR0nGd6jp

Can I get the INFLUENZA and COVID Vaccines together? The CDC says: "YES...both vaccines can be given at the same visit, people should follow the recommended schedule for either vaccine.... ideally get a flu vaccine by the end of October."  https://t.co/T49zm6Cxyc

MMWR shows the safety of a 3rd (booster) dose of the mRNA vaccine to be same as the 2nd dose AEs. V-safe data on 3rd dose (n=12,591) showed local or systemic effects (79% or 74%) to be same as 2nd dose (78% or 76%)  https://t.co/LcD0ARlWJ2

CDC Advises COVID-19 Vaccines for Pregnant Women https://rheumnow.com/news/cdc-advises-covid-19-vaccines-pregnant-women

U.S. Preventive Services Task Force (USPSTF) reaffirmed its recommendations that pregnant women at a high risk of preeclampsia should take a daily aspirin regimen at the end of the first trimester  https://t.co/DiV7p6g8vL

Is Acetaminophen Potentially Hazardous in Pregnancy?  https://rheumnow.com/news/acetaminophen-potentially-hazardous-pregnancy

#RA patients had an an increased risk of mortality after CABG (HR 1.50; 1.28-1.77); and a higher risk of MI following CABG (HR 1.61; 1.28-2.04). A retrospective Finnish study comparing RA (n= 378) to nonRA patients (n = 7560)  https://t.co/cGGsrLs1V2

Early Diastolic Dysfunction in Premenopausal Women with RA  https://rheumnow.com/news/early-diastolic-dysfunction-premenopausal-wom…

108 pts with autoimmune cytopenias (TTP, ITP, AIHA, etc) were given COVID vaccination showing low rate of post-vax flares. Signif HEME decreases in 7.4% of AIHA & ITP; mild decrease in 10% AIHA and 20% ITP, w/ no Rx change https://t.co/OaHILar57z

Global SECURE-IBD trial on IBD drugs and COVID shows that severe COVID-19 outcomes were not associated with the use of biologics and mesalamine/sulfasalazine, AZA, 6MP, MTX combo Rx or biologics (TNFi, IL-12/23, IL-23, integrin inhib)  https://t.co/MO4i5ngKkr

Questions & Cases
Approach to dental surgery while on bisphosphonate
Recurrent shingles while on adalimumab
Myositis after COVID-19 vaccine

CONNECT WITH RheumNow 
✩ Website - https://rheumnow.com/
✩ Subscribe @ RheumNow: https://rheumnow.com/user/register
✩ LinkedIn - https://www.linkedin.com/in/john-cush...
✩ RheumNow LinkedIn: https://www.linkedin.com/company/rheu...
✩ Twitter - https://twitter.com/RheumNow
Listen | PODCAST
Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/4Mjzj5j...
Stitcher: https://www.stitcher.com/show/the-rhe... 
TuneIn: https://tunein.com/podcasts/Health--W...
Podbean: https://rheumnow.podbean.com/
Got a Rheumatology question or case for Dr. Jack Cush? Record it here and we'll feature it on an upcoming podcast.  Tell us your name and where you practice rheumatology.
BackTalk: https://rheumnow.com/submit-podcast-q...

My Podcast Gift (12.24.2021)

My Podcast Gift (12.24.2021)

December 24, 2021

Merry Christmas and Happy Holidays from RheumNow.  Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence.

Indications Awaiting (12.17.21)

Indications Awaiting (12.17.21)

December 17, 2021

Dr Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.

Women Leaders in Rheumatology

Women Leaders in Rheumatology

December 14, 2021

A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountered during the COVID-19 pandemic..

Juvenile Psoriatic Arthritis and Enthesitis-Related Arthritis

Juvenile Psoriatic Arthritis and Enthesitis-Related Arthritis

December 14, 2021

There is a significant burden of disease associated with JPsA and ERA, with patients experiencing structural damage progression, risk of disability, and comorbidities that may persist into adulthood. This presentation led by Hermine Brunner, MD educates on the importance of early recognition and management.

RheumNow Podcast - ACR 2021 Rehash (the good stuff..)

RheumNow Podcast - ACR 2021 Rehash (the good stuff..)

December 13, 2021

The ACR 2021 meeting has concluded. Dr. Jack Cush recants a few more great abstracts from this past weeks meeting.

Podbean App

Play this podcast on Podbean App